State Street SPDR S&P 500 ETF (SPY) vs United Therapeutics Corporation (UTHR)
Over the past 10 years, UTHR lagged SPY — 15.01% vs 15.31% annualized total return (price plus dividends).
A side-by-side comparison of State Street SPDR S&P 500 ETF and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 18, 2026. Differences are shown without an overall score or investment verdict.
Total return — SPY vs UTHR
growth of $100 · dividends reinvested · last 10yMetrics side by side
Did UTHR beat SPY?
Over the past 10 years, UTHR lagged SPY — 15.01% vs 15.31% annualized total return (price plus dividends).
Total return (annualized)
| Metric | SPY | UTHR |
|---|---|---|
| Total return (1Y) | 21.30% | 62.01% |
| Total return CAGR (3Y) | 22.50% | 30.62% |
| Total return CAGR (5Y) | 13.24% | 20.07% |
| Total return CAGR (10Y) | 15.31% | 15.01% |
SPY is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).
Frequently asked
- Has UTHR beaten SPY?
- Over the past 10 years, UTHR lagged SPY — 15.01% vs 15.31% annualized total return (price plus dividends).
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 18, 2026.